Skip to content

ArriVent BioPharma, Inc.

AVBP· NasdaqCore metricsCIK 1868279

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.37%
Market cap
$675.76M
51.72M shares
Filings
162
$5.00M
Q3 2026
—
-$40.31M
Q3 2026N/M FY25 yoy
-$43.38M
Q3 2026N/M FY25 yoy
—
—
—
-$0.81
Q3 2026N/M FY25 yoy
$113.58M
Q3 2026−38.7% FY25 yoy
$675.76M
—
—
1.7×
—
—

FY2025 figures · derived

Price

$13.0732.38%$6.26past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$5.00MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

ArriVent BioPharma, Inc. is the 167th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

ArriVent BioPharma, Inc. · CIK 1868279 · Engraved from SEC EDGAR